Florida · 87637

Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in Florida

Florida Medicare Avg
$138.50
1% below national avg
National Medicare Avg
$139.61
All states combined
Billed Charge (FL)
$233.47
What providers submit
Est. Commercial (FL)
$325.48
National avg: $312.73
Est. Cash / Self-Pay (FL)
$168.08
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

3.2K
Services in FL
79
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Florida

Provider Medicare Services
Monarch Global Labs $139.78 1.2K
Millenia Advanced Scientific Llc $139.78 343
Laboratory Of Florida Llc $139.78 235
Cap Diagnostics Llc $139.78 232
Clarity Lab Solutions, Llc $139.78 197
My Clinical Lab Inc $106.83 116
Sea Level Labs Llc $139.78 75
Spector Scientific Lab Inc. $139.78 56
North Central Florida... $139.78 54

Florida Pricing in Context

In Florida, CPT code 87637 (Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus) carries an average Medicare payment of $138.50 — 1% below the national benchmark of $139.61. 79 providers across the state submitted claims for this procedure in 2023, performing 3.2K total services. Individual payments in FL ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Florida is $233.47, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Florida sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Laboratory procedures, the estimated commercial insurance price in Florida lands near $325.48, with self-pay cash prices typically around $168.08. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost in Florida?

The average Medicare payment for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in Florida is $138.50, which is 1% below the national average of $139.61. Providers in FL typically bill $233.47 for this procedure.

What does Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cost with insurance in Florida?

With commercial insurance in Florida, Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs an estimated $325.48. Without insurance, the estimated cash price is $168.08. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in Florida?

79 providers in Florida billed Medicare for Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus in 2023, performing 3.2K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus cheaper in Florida than the national average?

Yes — Detection Test By Multiplex Amplified Probe Technique For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-Cov-2) (covid-19), Influenza Virus Types A And B, And Respiratory Syncytial Virus costs 1% below the national average in Florida. The state average Medicare payment is $138.50 compared to $139.61 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial